December 20th 2024
As a result, the provider increases its involvement in the country’s pharma sector.
Democratizing AI: Bridging the Intelligence Divide in Commercial Life Sciences
March 14th 2022Small and emerging biopharma have been historically reserved about artificial intelligence. But, writes Alan Kalton, AI solutions have matured, been proven, and are no longer a risky investment for small to mid-size companies.